Author | David C. Smith, MD

Articles

Commentary (Smith/Sandler)-Testicular Cancer: Maintaining the High Cure Rate

February 01, 2003

As Dr. Raghavan has emphasizedin his excellent overviewof the current therapyfor testis cancer, it is critical that thesuccess of therapy for this diseasenot be compromised by a desire toavoid the complications of therapy.We would wholeheartedly agree withhis assertion that modifications intherapy must be introduced with athoughtful and structured approachto minimize the risk to efficacy.